Anti-FLT3 antibodies

Details for Australian Patent Application No. 2009260517 (hide)

Owner ImClone LLC

Inventors Lu, Dan; Tonra, James R.; Li, Yiwen; Surguladze, David

Agent Spruson & Ferguson

Pub. Number AU-A-2009260517

PCT Pub. Number WO2009/155015

Priority 61/130,395 30.05.08 US; 61/130,539 30.05.08 US; 61/130,394 30.05.08 US

Filing date 28 May 2009

Wipo publication date 23 December 2009

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

18 November 2010 PCT application entered the National Phase

  PCT publication WO2009/155015 Priority application(s): WO2009/155015

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009260519-Novel substituted azabenzoxazoles

2009260503-Wnt protein signalling inhibitors